Alan Edmund Walts serves as Executive at Eloxx Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Alan Edmund Walts has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 1, 2021 involved exercising options for 37,695 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 1, 2021 | ELOX | $0 | Option Exercise | 37,695 | $N/A | Discretionary |
Alan Edmund Walts currently holds 37,695 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Edmund Walts has been a net neutral trader of ELOX stock. They have purchased $0 and sold $0 worth of shares.
Alan Edmund Walts's most recent insider trade was on Dec 1, 2021, when they sold 37,695 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted